Friedreich's ataxia is a neurodegenerative disorder caused by mutations in the frataxin gene that produces a predominantly mitochondrial protein whose primary function appears to be mitochondrial iron -sulfur cluster (ISC) biosynthesis. Previously we demonstrated that frataxin interacts with multiple components of the mammalian ISC assembly machinery. Here we demonstrate that frataxin interacts with the mammalian mitochondrial chaperone HSC20. We show that this interaction is iron-dependent. We also show that like frataxin, HSC20 interacts with multiple proteins involved in ISC biogenesis including the ISCU/Nfs1 ISC biogenesis complex and the GRP75 ISC chaperone. Furthermore, knockdown of HSC20 caused functional defects in activity of mitochondrial ISC-containing enzymes and also defects in ISC protein expression. Alterations up or down of frataxin expression caused compensatory changes in HSC20 expression inversely, as expected of two cooperating proteins operating in the same pathway and suggesting a potential therapeutic strategy for the disease. Knockdown of HSC20 altered cytosolic and mitochondrial iron pools and increased the expression of transferrin receptor 1 and iron regulatory protein 2 consistent with decreased iron bioavailability. These results indicate that HSC20 interacts with frataxin structurally and functionally and is important for ISC biogenesis and iron homeostasis in mammals. Furthermore, they suggest that HSC20 may act late in the ISC pathway as a chaperone in ISC delivery to apoproteins and that HSC20 should be included in multi-protein complex studies of mammalian ISC biogenesis.
INTRODUCTION
Friedreich's ataxia (FRDA) is the most common autosomalrecessive inherited ataxia (1) and is caused by triplet expansions of (GAA) n that cause deficiency of frataxin, a nuclear-encoded, predominantly mitochondrial protein (2) . Most studies of frataxin's function have been carried out in bacteria and yeast and have yielded multiple insights into its physiological roles. The precise functions of frataxin in mammalian cells are still somewhat controversial, as roles in iron delivery (3) , iron sequestration (4) and iron-sulfur cluster (ISC) chaperoning are still discussed.
Frataxin is thought to support the biogenesis of ISCs, as its deficiency specifically affects ISC enzyme activity in mice and yeast (5, 6) . Microarray analysis of human cells has shown that frataxin depletion affects ISC-related transcripts preferentially (7) . Frataxin interacts with the ISC scaffold protein ISCU (8 -11) and the cysteine desulfurase Nfs1, and its accessory protein ISD11 (12 -15) , which are each components of the mitochondrial ISC assembly machinery. We observe that frataxin interacts with GRP75, a mitochondrial chaperone involved in delivery of ISC to apoproteins (12) . Other studies support a direct interaction of frataxin with ISCcontaining enzymes mitochondrial aconitase (16) , ferrochelatase (an ISC protein in mammals) (17) (18) (19) and succinate dehydrogenase (20, 21) .
A systems biology and evolutionary study showed that microbial frataxin co-evolved with the microbial chaperones heat shock cognate 66kDa; Hsc66 (HSCA) and heat shock cognate 20kDa; Hsc20 (HSCB), whose function is required for the insertion of 2Fe2S clusters into ferredoxin (22) , i.e. fxn/HSCA/ HSCB. In yeast, frataxin also interacts with mitochondrial HSCA homologs, the hsp70 protein ssq1, in the process of ISC biogenesis (Fig. 1) . Our previous work demonstrated interaction between frataxin and the human mitochondrial chaperone GRP75, which is a homolog to ssq1 in yeast and HscA in bacteria. But until now, no reports have shown that yeast frataxin yfh1 or mammalian frataxin interacts with an HSC20/HSCB/Jac1 protein. Although the exact function of mammalian HSC20 is not clearly known, in yeast its counterpart Jac1 is thought to transfer ISCs from Nfs1 to Ssq1 (23) , and in Escherichia coli its homolog HSCB is thought to catalyze the extrusion of the ISC from IscU, making it available to ISC apoproteins (24) . Here we show that mammalian HSC20 interacts with Nfs1/ISCU and GRP75, that HSC20 interacts with frataxin and that the interaction is important for the biogenesis of Fe -S clusters and iron homeostasis in mammals. Thus, HSC20 is a frataxin interactor that participates in mammalian iron -sulfur biogenesis.
RESULTS

Characterization and expression of HSC20
The human HSC20 protein sequence was searched within the National Center for Biotechnology Information database using BLAST, and homologs were found to exist in bacteria, yeast, plant and animals. Amino-acid sequence alignment reveals that human HSC20 shares 73% identity with its mouse homolog and the similarity of the amino-acid sequence of HSC20 with homologs in other organisms is 41% in Xenopus laevis, 38% in Danio rerio, 28% in Drosophila melanogaster, 25% in Arabidobsis thaliana, 23% in Saccharomyces cerevisiae and 29% in E. coli ( Fig. 2A) . Bioinformatic analysis indicates that HSC20 harbors a DnaJ domain at the N terminus and an HSCB_C domain at the C terminus (Fig. 2B) . In addition, a tetracysteine motif exists in the N terminus of all higher eukaryotes but not in yeast and bacteria. Phylogenetic analysis also indicates that HSC20 is an evolutionarily well-conserved gene (Fig. 2C) . We produced an HSC20 polyclonal antibody in rabbits, and this antibody recognized a band in mouse tissues and human cell lines (Fig. 2D) . To further study the function of HSC20, we constructed multiple HSC20 plasmids with tags on the C terminus and expressed them in mammalian cell lines ( Fig. 2E and F) . In the HEK293T cell lysate transfected with HSC20-Flag construct, both HSC20 polyclonal antibody (Fig. 2E, green) and Flag monoclonal antibody (Fig. 2E , red) detected two bands: one at 25 kDa and another protein at 28 kDa (Fig. 2E , middle lane). In the cell lysate transfected with HSC20-myc construct, myc polyantibody could detect two bands which are also detected by HSC20 antibody (Fig. 2E, lane 4) . The prediction of the HSC20 sequence by MitoProtII (25) suggested a 35 amino-acid signal peptide as expected for a mitochondrial protein, and this signal peptide could potentially be processed during the mitochondrial import of HSC20 peptide, consistent with the 28 kDa form being the precursor and the 25 kDa form as the mature mitochondrial form. The HSC20-Flag construct was overexpressed in HEK293T cells and immunoprecipitated with antiFlag antibody, and separated on a 15% sodium dodecyl sulfate -polyacrylamide gel electrophoresis (SDS -PAGE) gel and stained with Coomassie blue. The mature form band (25 kDa) was cut. Mass spectrometry analysis of the excised band produced the sequence SCDAASQAGSNYPR, corresponding to residues 27-40 of human HSC20, indicating that the relevant cleavage occurs between Lys26 and Ser27 (Fig. 2F) . The cleavage site matches the R-3 rule (26) . The mature form of HSC20 retains the conserved tetracysteine motif (C41-C61). To further confirm the cleavage site, we overexpressed the truncated HSC20 construct without first 26 amino acids and observed the same size band as the mature form of HSC20 (Fig. 2E, lanes 2 and 3) .
Physical and functional interaction between frataxin and HSC20
The co-evolutionary relationship between frataxin and HSC20 prompted us to study their interaction. To test an in vivo interaction between frataxin and HSC20, we co-transfected frataxin and HSC20 constructs into HEK293T cells. After 48 h, total protein was extracted and immunoprecipitated with Flag or HA antibodies, and western blots were probed with Flag and HA antibodies. The results indicated that frataxin-HA co-immunoprecipitates the precursor form of HSC20, and HSC20-Flag immunoprecipitates both intermediate and mature forms of frataxin (Fig. 3A) .
Next, we confirmed the in vitro interaction between frataxin and HSC20 by glutathione S-transferase (GST) pull-down assays. In this experiment, the mature form of frataxin (56 -210) was expressed as GST fusion protein as before (11) , and HSC20-GFP protein was expressed in HEK293T cells. The results of the GST pull-down assay indicated that the mature form of frataxin binds HSC20 protein (Fig. 3B) .
A further confirmation of interaction of HSC20' with frataxin was a test for endogenous interaction in mouse brains. For this test, whole-brain extracts from YG8 mice were lysed with CHAPS buffer, and lysates were immunoprecipitated with preimmune sera or HSC20 sera. After probing with frataxin antibody, a band was observed in the HSC20 immunoprecipitate at the predicted size, demonstrating that the mature form of frataxin interacts with HSC20 in neurological tissues (Fig. 3C) .
To further confirm the interaction between frataxin and HSC20, we used the blue native gel technique to isolate 
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Human Molecular Genetics, 2012, Vol. 21, No. 7 mitochondrial complexes from human lymphoblast cells. Then the complexes were further separated by SDS -PAGE in the second dimension (Fig. 3D ). Frataxin and HSC20 co-localize in these two-dimensional gels in the same fraction, consistent with the idea that frataxin forms a complex with HSC20. If frataxin interacts with HSC20 physically, the proteins should co-localize within cells. Frataxin-HA and HSC20-Flag constructs were co-transfected into COS7 cells. The expressed proteins were then stained with HA and Flag antibodies and visualized by immunofluorescence microscopy. Combining the two stains demonstrated that co-localization (Fig. 3E) is in a punctuate, extranuclear distribution.
As frataxin has been suggested to be an iron-binding protein that mediates iron delivery during ISC and heme biosynthesis (7, 18) , the influence of iron on the physical interaction between frataxin and HSC20 was tested. Physiological concentrations of ferrous iron (50 mM FeCl 2 ) increased the interaction of frataxin with HSC20, but the chelator ethylenediaminetetraacetic acid (EDTA) (Fig. 3F ) and ferrous iron chelator 2,2 ′ -dipyridyl (Supplementary Material, Fig. S1 ) obviously decreased the interaction.
Frataxin levels regulate HSC20 expression
Given the in vivo and in vitro interaction between frataxin and HSC20, and their co-regulation by iron, we studied whether frataxin regulates HSC20. Transfection of increasing amounts of frataxin produced a decreased expression of the HSC20 mature form (Fig. 3G) . The converse was also true, and frataxin knockdown produced increased expression of HSC20 expression (Fig. 3H , left three panels). In Friedreich's patient, lymphoblasts, frataxin, Nfs1 and ISCU expression are decreased (7); in contrast, HSC20 is increased, consistent with our other observations that frataxin depletion causes HSC20 increase (Fig. 3H, right panels) . The increment of HSC20 in the FRDA patient's cells could be decreased by mitochondrial iron chelator deferiprone (DFP; Fig. 3I ). Frataxin knockdown decreases both mitochondrial and cytosolic aconitase activity Interaction between HSC20 and frataxin was identified by co-immunoprecipitation. HEK293T cells were transiently transfected with pcDNA-Frataxin-HA and pcDNA-HSC20-Flag plasmids. After 48 h, cells were lysed and aliquoted and immunoprecipitated with indicated IgG or antibodies, followed by release of the immobile fraction and immunoblotting with anti-Flag (upper tier) and anti-HA antibodies (bottom tier). Input: 5% of the total cell lysates applied for the co-immunoprecipitation. (B) Frataxin interacts with HSC20 in vitro. GST-△55 frataxin pulls down HSC20-GFP. HEK293T cells were transiently transfected with pEGFPN-HSC20. Expression of GFP-tagged HSC20 is shown (lane 1). GST alone (lane 2) or GST-tagged frataxin (lane 3) was bound to beads and incubated with lysates of HEK293T cells transfected with pEGFPN-HSC20. Bead-bound protein complexes were subjected to immunoblotting. The gel was stained with Coomassie blue (upper tier) and the blot was probed with polyclonal anti-GFP antibody (bottom tier). (C) Endogenous interaction between frataxin and HSC20. YG8 mouse brains were homogenized with CHAPS buffer and immunoprecipitated with preimmune sera or HSC20 sera, followed by immunoblotting with anti-frataxin antibody. (D) Frataxin co-isolates with HSC20. Blue-native and SDS-PAGE 2D was applied to separate mitochondrial proteins. The native fraction was separated on the gradient gel in the first dimension, then the gel strip was stacked over Bis-Tris gradient gel and separated, the blot was immunoblotted against the HSC20 and frataxin. 
HSC20 is targeted to mitochondria
To experimentally determine the cellular compartment to which HSC20 localizes, we transfected HSC20-Flag vector into COS7 cells and stained mitochondria with MitoTracker red. The results clearly indicated that the HSC20-Flag fusion protein accumulates in the mitochondria (Fig. 4A , top tier).
In contrast, if the N-terminal 26 amino acids were removed, the cellular distribution of HSC20-Flag protein became diffuse but not mitochondrial (Fig. 4A , bottom tier). An HSC20 polyclonal antibody was produced in rabbits, and this antibody recognized both transfected and endogenous HSC20 (Fig. 2E) . Immunostaining of cells with this antibody showed that endogenous HSC20 was localized within the mitochondria (Fig. 4A , middle tier). Western blots demonstrate that the mature form of the HSC20 is the mitochondrial form (Fig. 4B ). Our HSC20 antibody recognized a 25 kDa band in mitochondria but not in cytosol. But we could not exclude cytosolic HSC20 because we observed cytosolic HSC20 in the HSC20Flag overexpressed cells (Supplementary Material, Fig. S3A ). In brief, HSC20 is predominantly located in mitochondria, whereas truncated HSC20 does not have a mitochondrial localization (Fig. 4A , bottom tier, Supplementary Material, Fig. S3B ).
HSC20 interacts with Nfs1/ISCU complex and GRP75
Because frataxin is known to interact with Nfs1/ISCU and GRP75, we tested whether similar interactions occurred among HSC20 and other components of the ISC biogenesis complex. HSC20-Flag, Nfs1-myc and ISCU-HA constructs were co-transfected into HEK293T cells, and cell lysates were aliquoted into two parts and immunoprecipitated with mouse IgG or Flag antibody, respectively. Immunoprecipitates were probed with Flag, myc and HA antibodies. Control mouse IgG did not precipitate myc or HA protein, but Flag antibody precipitated one myc-tagged protein at 50 kDa and two HA-tagged proteins at 15 and 17 kDa, respectively, which are the identical sizes as input lysate Nfs1-Myc and ISCU-HA (Fig. 5A) . These results suggest that HSC20 forms a complex with Nfs1/ISCU in vivo. ISCU protein is a scaffold protein for biogenesis of ISCs and also is a partner of frataxin, and their interaction is iron-dependent (8) . We tested the potential influence of iron on the physical interaction between HSC20 and ISCU. Physiological concentrations of ferrous iron (50 mM) increased the interaction among the proteins, whereas the chelator EDTA decreased the interaction (Fig. 5B) . To test the interaction between HSC20 and GRP75, we co-transfected HSC20-myc and GRP75-Flag constructs into HEK293T cells. Results showed that Flag antibody but not mouse IgG immunoprecipitated a 25 kDa band, i.e. the same size as the input lysate HSC20-myc mature form (Fig. 5C, left panels) . Also myc antibody, but not rabbit IgG, immunoprecipitated a 75 kDa band with Flag tag (Fig. 5C, right panels) . Thus, HSC20 interacts with Nfs1, ISCU and GRP75, and its interaction with ISCU is iron-independent (Supplementary Material, Fig. S4 ).
To further confirm the in vivo interaction between HSC20 and Nfs1/ISCU complex and GRP75, HSC20 construct and correspondent constructs were co-transfected into COS7 cells. Confocal microscopy was performed to verify co-localization. As shown in Fig. 5D , HSC20 co-localized very well with Nfs1, ISCU2 and GRP75.
Silencing HSC20 results in a cellular growth defect and impedes ISC biogenesis siRNAs were designed to knock down HSC20 to understand the consequences of its loss of function. siRNA oligonucleotides were co-transfected with the HSC20-myc construct into HEK293T cells for 48 h. As shown in Fig. 6A , all four HSC20 siRNA reduced the expression of HSC20-myc construct, with HSC20-1 being the most potent. HSC20-1 was used in the following experiments. After two rounds of transfections of this oligonucleotide, the endogenous HSC20 decreased more than 9-fold in HeLa cells (Fig. 6A) . Compared with the negative control siRNA, inhibition of proliferation was observed in HSC20-depleted cells. After second transfection, the HSC20-depleted cells were about half the number of controls and had slightly decreased the viability (Fig. 6B) . This decreased cellular growth is a common consequence of knockdown of iron -sulfur machinery in mammalian cells (27, 28) and also occurs as a consequence of frataxin knockdown (6) .
To explain the importance of HSC20 for the function of mammalian mitochondrial ISC proteins, we knocked down HSC20 in HeLa cells and measured the activities of the ISCcontaining enzymes aconitase and succinate dehydrogenase and non-ISC-containing enzymes citrate synthase and malate dehydrogenase. There was a clear and significant decrease in mitochondrial ISC-requiring aconitase and SDH activities. In contrast, there was no significant decrease in the activities of mitochondrial enzymes that lack ISCs, citrate synthase or malate dehydrogenase (Fig. 6C) . To assay mitochondrial and cytosolic aconitase activities, an aconitase activity stain was performed. Control cells showed two dark blue activity bands, whereas much weaker bands in HSC20-deficient cells (Fig. 6D) . Transfection with siRNA HSC20-1 decreased mitochondrial aconitase activity by 52% and cytosolic aconitase activity by 85%. Similarly, siRNA HSC20-2 transfection decreased mitochondrial and cytosolic aconitase activity by 36 and 74%, respectively. Thus, HSC20 deficiency depletes ISC enzyme activity both in mitochondria and cytosol. To further demonstrate that the aconitase defect phenotype was caused specifically by HSC20 knockdown, a rescue experiment was performed. HSC20 constructs were mutated (silence mutation) to resist the siRNA HSC20-1 and co-transfected with this siRNA. Transfection of full-length HSC20 produced a complete rescue of cytosolic aconitase activity, whereas transfection of the deletion mutant HSC20 construct del26 did not (Fig. 6E) . This supports the idea that mitochondrial localization of HSC20 is necessary for its function in maintenance of cytosolic ISC enzyme activity.
To further investigate the downstream and functional consequences of HSC20 silencing, we investigated expression of six proteins containing ISCs (Fig. 6F ): ferredoxin 2 (Fdx2), iron regulatory protein 1 (IRP1), succinate dehydrogenates B (SDHB), ferrochelatase (FeCH), NADH dehydrogenase [ubiquinone] iron-sulfur protein 3 (NDUFS3) and mitochondrial aconitase (mtAco). All but NDUFS3 decreased expression as a consequence of HSC20 silencing, consistent with an effect of HSC20 on ISC biogenesis.
Deficiency of HSC20 misregulates iron metabolism and increases reactive oxygen species
Previous studies revealed that iron homeostasis was disturbed in yeast strains bearing mutations in Jac1, the HSC20 homolog (29), thus we investigated the function of HSC20' in iron metabolism. The conserved tetracysteine motif of HSC20 is a potential iron-binding site. We mutated these cysteines to serines and transfected identical amounts of constructs into HEK293T cells. HSC20 expressions were monitored by Flag antibody. 
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Mutation of the cysteines significantly decreased the expression of HSC20 (Fig. 7A) . We treated HeLa cells with ferric ammonium citrate (FAC) to overload iron and desferrioxamine (DFO) to deplete iron. As expected, FAC-mediated iron overload decreases transferrin receptor 1 (TfR1) and increases Ferritin, whereas DFO-mediated iron depletion decreases Ferritin and increases TfR1 (Fig. 7B) . The expression of both frataxin and HSC20 decreased under DFO-mediated iron depletion, but did not change with FACmediated iron overload. We measured cellular iron content in control and HSC20-depleted cells. Compared with the control cells, the HSC20-depleted cells showed a significant increase in total iron content (Fig. 7C) . Further iron assay showed that mitochondrial iron of HSC20-depleted cells was increased by 25% over control samples, whereas cytosolic iron was decreased by 11% (Fig. 7C) . These results indicated cytosolic iron deficiency and iron accumulated in mitochondria. We quantified multiple proteins involved in iron metabolism in HSC20-depleted cells. HCS20 knockdown caused increases in Ferroportin (FPN, iron export proteins), iron regulatory protein 2 (IRP2) and TfR1 and a decrease in the iron storage protein ferritin (Fig. 7D ). IRP1 decreased in HSC20-depleted cells as mentioned earlier (Fig. 6F) .
Our previous data demonstrated an increase in mitochondrial superoxide in FRDA lymphoblasts (10) . So here we measured the amount of mitochondrial superoxide in both control and HSC20-depleted cells by the DHE method. An increased production of mitochondrial superoxide was observed in HSC20-depleted cells relative to controls (Fig. 7E) . We verified the specificity of the assay by treating HeLa cells with stimulator of mitochondrial reactive oxygen species (ROS) production, antimycin A. As expected, a near doubling of the fluorescence observed in the antimycin A-treated cells.
DISCUSSION
Human HSC20 is a highly conserved mitochondrial protein
Biogenesis of ISCs is an important function across genera, and the proteins that facilitate this function are conserved. In eukaryotes, mitochondria are central to ISC biogenesis (30) and so far the eukaryotic studies of ISC biogenesis are mainly described in yeast. HSC20 is highly conserved from E. coli to humans, suggesting a conserved function. HSC20 contains a DnaJ domain, which in bacteria and yeast mediates the interaction with HSCA (31). HSC20 also contains an HSCB-C domain, which represents the C-terminal oligomerization signal in the HscB protein, and is thought to bind and target proteins to HscA (32) . The crystal structure of human HSC20 shows that there is a potential iron-binding tetracysteine motif on the N terminus (33) . Evolutionary comparison shows that the tetracysteine motif is widely distributed in metazoan eukaryotes but not in yeast and bacteria, suggesting that this motif was added in metazoan evolution. The novel tetracysteine motif may have a novel function in metazoans compared with yeast and bacteria. However, we observed that mutation of this motif severely decreased protein expression (Fig. 7A) , suggesting that this presumed ironbinding site is important for the stability of HSC20 protein.
HSC20 interacts with frataxin
Huynen et al. (22) elucidated the identical phylogenetic distribution of frataxin, HSCA and HSCB among the 20 ISC-related proteins. Previously we found that mammalian frataxin interacts with GRP75/HSCA (11) . Frataxin and HSC20 are co-expressed in human tissues, in that human frataxin mRNA is mainly expressed in the heart, liver and skeletal muscle (2) , and human HSC20 mRNA also is mainly expressed in these three tissues (34) . Here we demonstrate a physical interaction between frataxin and HSC20 by several criteria, and this interaction is increased by ferrous iron and inhibited by the chelator EDTA and ferrous chelator 2,2 ′ -dipyridyl (Supplementary Material, Fig. S1 ). The yeast frataxin homolog interacts with Nfs1/ISU, and this interaction is increased by ferrous iron (9) . The data suggest that ferrous iron supports the interaction of frataxin and HSC20, and thus ISC biogenesis.
HSC20 expression is inversely related to frataxin expression and may function downstream in mitochondrial ISC biogenesis
We observed an inverse relation of frataxin expression to that of HSC20. Overexpression of frataxin inhibited the expression of the mature, functional form of HSC20. Conversely, frataxin knockdown and frataxin deficiency, as a result of the Friedreich's mutation, increased HSC20 expression. This is expected behavior of two gene products with compensatory function working in the same pathway. Supporting this idea, we observed that overexpression of HSC20 rescued a defect in mitochondrial aconitase activity caused by frataxin knockdown. This suggests a potential therapeutic strategy for FRDA, i.e. to design small-molecule compounds those mimic the function of HSC20, and thus rescue frataxin deficiency. In contrast, overexpression of HSC20 did not inhibit the expression of frataxin construct (Supplementary Material, Fig. S2A ). Interestingly, a full-length HSC20 construct could increase the expression of endogenous frataxin, but a truncated construct could not (Supplementary Material, Fig. S2B ). This suggests that HSC20 could stabilize frataxin in the mitochondria. Further study showed that frataxin significantly decrease in the HSC20-depleted cells (Supplementary Material, Fig. S2C and D) . It seems that frataxin amount is proportional to the residue HSC20 amount (Supplementary Material,  Fig. S2C ). Thus, frataxin levels regulate HSC20 in an inverse relationship, and HSC20 could stabilize frataxin. These data suggest that the tight functional connection between HSC20 and frataxin and HSC20 may function later than frataxin in the pathway of ISC biogenesis.
HSC20 interacts with multiple components of the ISC biogenesis complex and its deficiency causes ISC deficiency
The yeast HSC20 ortholog Jac1 interacts with the ISC scaffold protein IscU and the ISC chaperone Ssq1 (29, 35) . Also in yeast, Jac1 mutants have reduced activities of the ISC Human Molecular Genetics, 2012, Vol. 21, No. 7 1463 enzymes mitochondrial aconitase and succinate dehydrogenase (36) . Functionally, we observed that knockdown of the human HSC20 reduces ISC enzyme activities and decreases ISC-containing proteins. Also, we observed interaction between human HSC20, and human ISCU/Nfs1 complex and GRP75. Thus, the ISC function of human HSC20 protein appears to be conserved in both function and structure from microbes to humans. Frataxin deficiency causes decreased expression of some ISC assembly proteins and ISC-containing proteins (7, 37) . We observed that HSC20 deficiency decreases ISC assembly proteins and ISC-containing enzymes. These results are identical with frataxin deficiency, suggesting that frataxin and HSC20 functions are tightly related.
We provided multiple lines of direct support for the ISC biogenesis function of HSC20: (1) HSC20 interacts with ISC assembly proteins; (2) HSC20 deficiency causes decreased activity of ISC-requiring enzymes; and (3) HSC20 deficiency decreases expression of both ISC assembly proteins and ISC-containing proteins.
Mitochondrial location of HSC20
The mitochondrial location of HSC20 appears to be important for its function in ISC biogenesis. Yeast studies show that mitochondria are the center of ISC biogenesis (30, 38) . But other studies show that many ISC genes have alternative splice sites that produce cytosolic forms in mammals (39) (40) (41) . We observed cytosolic HSC20 in the HSC20-Flag overexpressing cells (Supplementary Material, Fig. S3A ) but not in non-transfected cells (Fig. 4B) . So, HSC20 predominantly localizes on mitochondria and we cannot exclude the existence of trace amount endogenous cytosolic HSC20. We confirmed that the first 26 amino acids are HSC20 mitochondrial leader sequence. Deletion of these 26 amino acids gives HSC20 protein an extra-mitochondrial distribution (Fig. 4A , Supplementary Material, Fig. S3B ). We also show that HSC20 depletion decreases the activities of mitochondrial enzymes that require ISCs but not those non-ISC enzymes. Consistent with this, a mitochondrial-localized HSC20 rescued the deficiency in aconitase activity caused by HSC20 knockdown, whereas transfection of HSC20 lacking the mitochondrial leader did not rescue (Fig. 6E) . These results suggest that mitochondrial location is important for the function of HSC20 in ISC biogenesis.
HSC20 deficiency appears to deplete iron bioavailability and increase ROS
In addition to its effects on ISCs, alterations in HSC20 also affected iron metabolism. Iron deprivation decreased the expression of both frataxin and HSC20 (Fig. 7B) . Conversely, HSC20 knockdown changed the distribution of cellular iron, perhaps as a result of deficient ISC assembly. HSC20 depletion also increased the iron uptake protein TfR1 and decreased the iron sequestration protein ferritin. This suggests that knockdown of HSC20 decreases bioavailable iron.
Bioavailable iron is sensed by the IRP1/IRP2 system. HSC20 knockdown significantly increased IRP2. IRP2 levels increase in cells that have cytosolic iron deficiency (42, 43) , consistent with the decrease of cytosolic iron in the HSC20-depleted cells. Thus, we infer that HSC20 knockdown decreases cytosolic iron bioavailability. We have reported previously a decreased cytosolic iron and altered iron bioavailability in frataxin-deficient cells (44) . Although bioavailability of iron is limited, the pathological accumulation of the metal within tissues aggravates the generation of ROS (45). Here we observed mitochondrial iron overload and an increased production of mitochondrial superoxide in HSC20-depleted cells. We observed similar phenotype in frataxin-deficient cells (11, 44) , further supporting a tight functional connection between frataxin and HSC20.
Possibilities for HSC20 function in post-ISC synthesis and iron metabolism
The function of HSC20 appears to be tightly connected with the function of frataxin and ISC biogenesis. HSC20 has a putative tetracysteine iron-binding domain (Fig. 2B) . This raises the possibility that HSC20 can bind iron or donate iron to form ISC. HSC20 partly rescue the mitochondrial aconitase defect caused by frataxin deficiency (Fig. 3I) . One possible explanation is that HSC20 delivers ISC to mitochondrial aconitase or donates iron and converted mitochondrial aconitase from the inactive [3Fe -4S] form to the active [4Fe -4S] form.
Similar to HSC20, frataxin deficiency would cause mitochondrial iron overload and ROS increment (44) . We observe the upregulation of HSC20 in frataxin-deficient cells. HSC20 could be a potential mitochondrial iron sensor. Iron overload in mitochondria of frataxin-deficient cells stimulate the expression of HSC20. And mitochondrial chelator DFP reduced mitochondrial labile iron in the FRDA patient's Figure 6 . Silencing HSC20 impedes ISC biogenesis and increases ROS. (A) HSC20-1 siRNA-mediated knockdown reduces both overexpressed HSC20 and endogenous HSC20. Left: HEK293T cells were transfected with the corresponding oligos as above, after 48 h, cell lysates were analyzed by myc and actin antibodies. Right: HeLa cells were transfected two round siRNA (50 nM) and at Days 3 and 6 (from the day that seeded cells), cells were harvested, lysed and cell lysates were analyzed with HSC20 antibody and actin antibody. (B) HSC20 siRNA knockdown decreases cell viability and inhibits cell proliferation. (C) HSC20 knockdown decreases the ISC-containing enzymes aconitase and SDH activities, but not non-ISC-containing enzymes activities. HeLa cells were transfected with 50 nM control siRNA or HSC20 siRNA, after 48 h, whole-cell lysates were used to analyze enzymatic activity (aconitase, malate dehydrogenase, citrate synthase). And for succinate dehydrogenase, mitochondria were isolated and used for the enzymatic analysis. (D) HSC20 knockdown decreases both mitochondrial and cytosolic aconitase activities. HeLa cells were transfected with control siRNA, HSC20-1 siRNA or HSC20-2 siRNA. After 48 h, 100 mg of whole-cell lysates were used to aconitase activity gel analysis. The densitometry of bands were analyzed and showed on the right. (E) Cytosolic form HSC20 cannot recover cytosolic aconitase activity caused by HSC20 knockdown. HeLa cells were transfected with corresponding siRNA and corresponding plasmid as above (mut, both pcDNA-HSC20Flag and pcDNA-del26HSC20Flag plasmids were silently mutated to generate HSC20-1 siRNA-resistant plasmids). After 48 h, 100 mg of whole-cell lysates were used to aconitase activity gel analysis. (F) The proteomic change of ISC biogenesis in HSC20 depleted cells. cells, further reducing up-modulated HSC20 level (Fig. 3I) . So, in another way, HSC20 could bind additional mitochondrial labile iron, ameliorating the damage of aconitase function caused by iron toxicity. The mitochondrial iron sensor function of HSC20 need to be further studied in future.
Some recent studies have demonstrated interactions of frataxin with multiple ISC-containing proteins not directly involved in ISC biogenesis, including mitochondrial aconitase (16) , succinate dehydrogenase (12, 20, 21) , ferrochelatase (17 -19) and cytosolic IRP1 (46) . Thus, it is possible that frataxin and HSC20 work together with GRP75 post-ISC synthesis, as ISC chaperones, to deliver ISCs to these apoproteins. A proposed model for the function of HSC20 and frataxin in ISC metabolism was shown in Fig. 8 . . HSC20 knockdown leads to increased TfR1, FPN, IRP2 and decreased ferritin protein levels. (E) Superoxide production in control and HSC20-depleted cells. The experiment was repeated three times and * * P , 0.01, * * * P , 0.001.
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Summary and prospects
Taken together, these results demonstrate that HSC20 is a mitochondrial-localized frataxin partner and functions in the ISC pathway, because deficiencies in HSC20 caused defects in ISC enzyme activity and ISC protein expression. The inverse regulation of HSC20 by frataxin suggests compensatory function in the same pathway and also suggests a potential therapeutic strategy in the design of small-molecule mimics of HSC20. In addition, HSC20 depletion caused an increase in mitochondrial iron (and ROS) and a decrease in bioavailable cytosolic iron. Recent studies of the function of assembled frataxin, Nfs1, ISCU and ISD11 have suggested that in this context, frataxin acts as an allosteric effector for sulfide activation (14) . Our data suggest that HSC20 may act later in the pathway, at the point of delivery of ISCs to apoproteins and should be included in vitro reconstruction studies of ISC biogenesis. The further specification of the interaction between HSC20 and frataxin and the role of HSC20 in ISC biogenesis and delivery will increase the mechanistic understanding of ISC biogenesis and FRDA.
MATERIALS AND METHODS
Biochemical reagents were purchased from Sigma (St Louis, MO, USA), Bio-Rad (Hercules, CA, USA) or mentioned in the text. DFP (sold as Ferriprox) was from Apopharm (Toronto, Ont., Canada).
Cell culture
All cells were maintained at 378C in a humidified atmosphere incubator containing 5% CO 2 . COS7, human oligodendroglioma (HOG) cell line, HeLa, T265 (Schwann cell line) and HEK293T cells (from ATCC) were grown in Dulbecco's modified Eagle medium (DMEM) medium (Gibco-BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum and 1 mM sodium pyruvate. Lymophoblast cells were cultured as before (12) . Cell viability was measured by Vi-Cell TM Analyser (Beckman Courlter, Brea, CA, USA).
Plasmid constructs and site-directed mutagenesis
Full-length human HSC20 cDNA (GenBank Accession No. NM_172002) or C-terminal Flag sequence (gactacaaggacgacg atgacaagtaa) was inserted into pcDNA3.1-myc-his separately; the frataxin and GRP75 constructs were described previously (12) . The D26, C41SC44S and C58SC61S of HSC20 mutant plasmids were obtained from pcDNA-HSC20-Flag by sitedirected mutagenesis using the QuikChange site-directed mutagenesis kit (Stratagene, Santa Clara, CA, USA) and all mutants were sequenced to confirm their sequences. pXS-Nifs-myc and pSX-ISCU2HA were kind gifts from Dr Tracey Rouault and Wing-Hang Tong.
Western blot analysis
Forty micrograms of whole-cell lysates, 40 mm of cytosolic proteins or 20 mm of mitochondrial proteins were analyzed on SDS gel or Bis-Tris gels (Invitrogen, Carsbad, CA, USA). Electrophoresis was carried out according to the manufacturer's instruction. After electrophoresis, the proteins were transferred to nitrocellulose membranes by iBlot device (Invitrogen). The membranes were blocked with blocking buffer (Odyssey, Lincoln, NE, USA) for 1 h and incubated overnight with the following primary antibodies in blocking buffer: anti-frataxin; anti-ISCU, Nfs1 and IRP2 (kind gifts from Drs Tracey Rouault and Wing-Hang Tong); rabbit anti-IRP1 (a kind gift from Dr Rick Eisenstein); rabbit antimitochondrial aconitase (a kind gift from Dr Luke Szweda); FPN (a kind gift from Dr David Haile), Fdx2 (a kind gift from Dr Lill Roland); rabbit anti-ISD11; mouse anti-cytochrome c (BD Pharmingen, Franklin Lakes, NJ, USA), anti-b-actin, tubulin, Flag (Sigma), mouse anti-myc (ABR, Golden, CO, USA), mouse anti-green fluorescent protein (GFP; NeuroMab, Davis, CA, USA), rabbit anti-GFP (Abcam, Cambridge, MA, USA), SDHB, COXII and NDUFS3 (Mitoscience, Eugene, OR, USA). Afterwards, the membranes were incubated with a corresponding pair of IRDye 680CW-and IRDye 800CW-coupled (Odyssey) secondary antibodies for 1 h. The membranes were washed four times with 1× Tris-buffered saline with Tween 20 and proteins were visualized with a LI-COR infrared imager (Odyssey). The pictures were processed by Odyssey version 3.0 infrared imaging software. phenylmethylsulfonyl fluoride and EDTA-free complete protease inhibitor cocktail (Roche). The whole-cell lysates were incubated with anti-Flag-M2 resin, anti-HA agarose (Sigma), Anti-myc (ABR) or rabbit polyclonal anti-frataxin antibody and rProtein G Agarose at 48C, rotated overnight and washed four times with lysis buffer. Precipitates were analyzed by western blotting using anti-Flag, anti-myc or antifrataxin antibody.
Co-immunoprecipitation assays
Immunofluorescence analysis COS7 cells were plated on coverslips in 6-well plates. For mitochondrial localization, pcDNA-HSC20-Flag plasmid was transfected into COS7 cells cultured for 24 h, exposed to 100 nM MitoTracker Red CMX (Molecular Probe, Eugene, OR, USA) for 1 h at 378C and then fixed in 3.7% paraformaldehyde for 30 min at 48C and pre-chilled methanol 10 min at 2208C. After washing once with phosphate-buffered saline (PBS), the cells were permeabilized with 0.25% Triton X-100/PBS for 5 min and then washed three times in PBS followed by blocking in fresh 1% bovine serum albumin/PBS for 30 min at 378C. Then the cells were incubated with the primary antibody at 48C overnight. The primary antibody consisted of anti-Flag mAb. After overnight incubation, the coverslips were rinsed three times in PBS and reacted for 1 h with goat anti-mouse fluorescein (Jackson ImmunoResearch, West Grove, PA, USA) in the dark. Cells were washed three times in PBS mixture in a mounting media. For co-localization, corresponding plasmids were co-transfected into COS7 cells. The primary antibodies were consisted of the rabbit polyclonal anti-HA/myc antibody and anti-Flag mAb. Secondary antibodies were goat anti-rabbit fluorescein conjugate (Jackson ImmunoResearch) and goat anti-mouse rhodamine (Jackson ImmunoResearch). All samples were imaged using Olympus confocal microscope.
RNA interference (RNAi), iron measurement and aconitase activities HSC20 short interfering RNA oligonucleotides and negative control oligonucleotides were purchased from Qiagen (Valencia, CA, USA). HeLa cells at a confluency of 30-50% were transfected with 50 nM siRNA using Lipofectamine 2000 (Invitrogen) every 72 h for 3 -6 days (48), total cellular iron was determined under reduction conditions with Ferrozine as chelator and reactions were carried on in a disposable 2-ml polypropylene tubes with screw caps from Sarstedt (Newton, NC, USA) (49) . Cytosol and mitochondrial irons were determined using QuantiChrom Iron Assay Kit (BioAssay Systems, Hayward, CA, USA). Aconitase activities were analyzed in aconitase activity gels (41) .
ROS measurements
ROS measurements were performed by dihydroethidium (DHE) staining as before (50) . Briefly, cells were trypsinized and resuspended in PBS (0.5 × 10 6 cells/ml) supplemented with 2 mM DHE and incubated at 378C. Cells treated with mitochondrial inhibitors received 10 mM antimycin A. Fluorescence readings were recorded at 530 -620 nm for 2 h.
Statistics
Statistical analysis of the data was performed by Student's t-test.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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